GKOS

GLAUKOS Corp

NYSE · Surgical & Medical Instruments & Apparatus

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Glaukos Corp develops and sells medical devices for treating glaucoma and other eye conditions, including micro-invasive surgical implants and pharmaceutical therapies used by ophthalmologists.

Industry

Surgical & Medical Instruments & Apparatus

Headquarters

Aliso Viejo, CA

Exchange

NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$54K	327at $164.78	Oct 5, 2026
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$146K	888at $163.93	Oct 5, 2026
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$52K	312at $165.60	Oct 5, 2026
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$21K	136at $152.71	Sep 25, 2026
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$25K	167at $151.70	Sep 25, 2026
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$168K	1,083at $154.88	Sep 25, 2026
Navratil TomasCHIEF DEVELOPMENT OFFICER	Sell	$35K	229at $154.24	Sep 25, 2026
Kliman Gilbert HInsider	Sell	$475K	2,500at $190.00	Aug 19, 2026
Gilliam Joseph EPRESIDENT & COO	Sell	$5.78M	32,037at $180.49	Aug 11, 2026
Gilliam Joseph EPRESIDENT & COO	Sell	$5.00M	27,963at $178.89	Aug 11, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for GKOS.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable GKOS activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

Mobile number (optional)

SMS is optional: we only save your number if you check the consent box and provide a valid number. Outside US/Canada, include + and your country code.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.